UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Therapy for Stage IV Non-Small-Cell Lung Cancer Without Driver Alterations: ASCO and OH (CCO) Joint Guideline Update

Journal of clinical oncology, 2020-05, Vol.38 (14), p.1608-1632

2020

Volltextzugriff (PDF)

A phase 2 trial of chemotherapy plus pembrolizumab in patients with advanced non–small cell lung cancer previously treated with a PD‐1 or PD‐L1 inhibitor: Big Ten Cancer Research Consortium BTCRC‐LUN15‐029

Cancer, 2023-01, Vol.129 (2), p.264-271

2023

Volltextzugriff (PDF)

Testicular Cancer — Discoveries and Updates

The New England journal of medicine, 2014-11, Vol.371 (21), p.2005-2016

2014

Volltextzugriff (PDF)

Impact of smoke-free ordinance strength on smoking prevalence and lung cancer incidence

PloS one, 2021-04, Vol.16 (4), p.e0250285-e0250285

2021

Volltextzugriff (PDF)

Therapy for Stage IV Non-Small-Cell Lung Cancer Without Driver Alterations: ASCO and OH (CCO) Joint Guideline Update Summary

JCO oncology practice, 2020-08, Vol.16 (8), p.e844-e848

2020

Volltextzugriff (PDF)

Phase II trial of brentuximab vedotin in relapsed/refractory germ cell tumors

Investigational new drugs, 2021-12, Vol.39 (6), p.1656-1663

2021

Volltextzugriff (PDF)

LAL deficiency induced myeloid-derived suppressor cells as targets and biomarkers for lung cancer

Journal for immunotherapy of cancer, 2023-03, Vol.11 (3), p.e006272

2023

Volltextzugriff (PDF)

Differential Effects of Gefitinib and Cetuximab on Non–small-cell Lung Cancers Bearing Epidermal Growth Factor Receptor Mutations

JNCI : Journal of the National Cancer Institute, 2005-08, Vol.97 (16), p.1185-1194

2005

Volltextzugriff (PDF)

Adenocarcinoma Harboring EGFR-RAD51 Fusion Treated With Osimertinib: A Case Report

JTO clinical and research reports, 2024-04, Vol.5 (4), p.100652, Article 100652

2024

Volltextzugriff (PDF)

High-Dose Chemotherapy and Autologous Peripheral-Blood Stem-Cell Transplantation for Relapsed Metastatic Germ Cell Tumors: The Indiana University Experience

Journal of clinical oncology, 2017-04, Vol.35 (10), p.1096-1102

2017

Volltextzugriff (PDF)

Lysosomal acid lipase, CSF1R, and PD-L1 determine functions of CD11c+ myeloid-derived suppressor cells

JCI insight, 2022-09, Vol.7 (17)

2022

Volltextzugriff (PDF)

Therapy for Stage IV Non-Small-Cell Lung Cancer With Driver Alterations: ASCO and OH (CCO) Joint Guideline Update

Journal of clinical oncology, 2021-03, Vol.39 (9), p.1040-1091

2021

Volltextzugriff (PDF)

A phase II trial of olanzapine, dexamethasone, and palonosetron for the prevention of chemotherapy-induced nausea and vomiting: a Hoosier oncology group study

Supportive care in cancer, 2007-11, Vol.15 (11), p.1285-1285, Article 1285

2007

Volltextzugriff (PDF)

Testicular cancer: The usage of central review for pathology diagnosis of orchiectomy specimens

Urologic oncology, 2017-10, Vol.35 (10), p.605.e9-605.e16

2017

Volltextzugriff (PDF)

The SMILE scale: a wellness behavioral tool for patients with cancer

Quality of life research, 2024-09

2024

Volltextzugriff (PDF)

Management of Residual Nonretroperitoneal Disease in Postchemotherapy Nonseminomatous Germ-Cell Tumors

Journal of clinical oncology, 2023-08, Vol.41 (23), p.3939-3944

2023

Volltextzugriff (PDF)

TMPRSS2-ERG fusion in an uncommon presentation of prostate cancer

Clinical genitourinary cancer, 2017-06, Vol.15 (3), p.e489-e491

2017

Volltextzugriff (PDF)

Primary Retroperitoneal Lymph Node Dissection for Stage II Seminoma: Is Surgery the New Path Forward?

Journal of clinical oncology, 2023-08, Vol.41 (23), p.3930-3938

2023

Volltextzugriff (PDF)

Phase I/II trial of plinabulin in combination with nivolumab and ipilimumab in patients with recurrent small cell lung cancer (SCLC): Big ten cancer research consortium (BTCRC-LUN17-127) study

Lung cancer (Amsterdam, Netherlands), 2024-09, Vol.195, p.107932, Article 107932

2024

Volltextzugriff (PDF)

A phase II study assessing the safety and efficacy of ASP1650 in male patients with relapsed refractory germ cell tumors

Investigational new drugs, 2022-10, Vol.40 (5), p.1087-1094

2022

Volltextzugriff (PDF)

Surveillance after Complete Response to First-Line Chemotherapy in Patients with Metastatic Nonseminomatous Germ Cell Tumor

The Journal of urology, 2022-09, Vol.208 (3), p.641-649

2022

Volltextzugriff (PDF)

Survival outcomes and toxicity in patients 40 years old or older with relapsed metastatic germ cell tumors treated with high‐dose chemotherapy and peripheral blood stem cell transplantation

Cancer, 2021-10, Vol.127 (20), p.3751-3760

2021

Volltextzugriff (PDF)

Nintedanib plus pemetrexed versus placebo plus pemetrexed in patients with relapsed or refractory, advanced non-small cell lung cancer (LUME-Lung 2): A randomized, double-blind, phase III trial

Lung cancer (Amsterdam, Netherlands), 2016-12, Vol.102, p.65-73

2016

Volltextzugriff (PDF)

Electronic nicotine delivery systems: a policy statement from the American Association for Cancer Research and the American Society of Clinical Oncology

Journal of clinical oncology, 2015-03, Vol.33 (8), p.952-963

2015

Volltextzugriff (PDF)

1 – 25 von 217

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(207)
Mit Volltextzugriff
(196)

Publikationsform

Sprache

Englisch
(217)

Erscheinungsjahr

n.n

Thema

Science & Technology
(88)
Life Sciences & Biomedicine
(85)
Humans
(70)
Oncology
(66)
Male
(52)
Middle Aged
(34)
Female
(32)
Adult
(29)
Aged
(29)
Lung Neoplasms - Drug Therapy
(24)
Lung Cancer
(23)
Carcinoma, Non-Small-Cell Lung - Drug Therapy
(21)
Aged, 80 And Over
(18)
Lung Neoplasms - Pathology
(18)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(16)
Chemotherapy
(16)
Respiratory System
(15)
Treatment Outcome
(15)
Carcinoma, Non-Small-Cell Lung - Pathology
(14)
Neoplasm Staging
(14)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Therapy for Stage IV Non-Small-Cell Lung Cancer Without Driver Alterations: ASCO and OH (CCO) Joint Guideline Update

A phase 2 trial of chemotherapy plus pembrolizumab in patients with advanced non–small cell lung cancer previously treated with a PD‐1 or PD‐L1 inhibitor: Big Ten Cancer Research Consortium BTCRC‐LUN15‐029

Testicular Cancer — Discoveries and Updates

Impact of smoke-free ordinance strength on smoking prevalence and lung cancer incidence

Therapy for Stage IV Non-Small-Cell Lung Cancer Without Driver Alterations: ASCO and OH (CCO) Joint Guideline Update Summary

Phase II trial of brentuximab vedotin in relapsed/refractory germ cell tumors

LAL deficiency induced myeloid-derived suppressor cells as targets and biomarkers for lung cancer

Differential Effects of Gefitinib and Cetuximab on Non–small-cell Lung Cancers Bearing Epidermal Growth Factor Receptor Mutations

Adenocarcinoma Harboring EGFR-RAD51 Fusion Treated With Osimertinib: A Case Report

High-Dose Chemotherapy and Autologous Peripheral-Blood Stem-Cell Transplantation for Relapsed Metastatic Germ Cell Tumors: The Indiana University Experience

Lysosomal acid lipase, CSF1R, and PD-L1 determine functions of CD11c+ myeloid-derived suppressor cells

Therapy for Stage IV Non-Small-Cell Lung Cancer With Driver Alterations: ASCO and OH (CCO) Joint Guideline Update

A phase II trial of olanzapine, dexamethasone, and palonosetron for the prevention of chemotherapy-induced nausea and vomiting: a Hoosier oncology group study

A phase 2 trial of consolidation pembrolizumab following concurrent chemoradiation for patients with unresectable stage III non–small cell lung cancer: Hoosier Cancer Research Network LUN 14‐179

Testicular cancer: The usage of central review for pathology diagnosis of orchiectomy specimens

The SMILE scale: a wellness behavioral tool for patients with cancer

Management of Residual Nonretroperitoneal Disease in Postchemotherapy Nonseminomatous Germ-Cell Tumors

TMPRSS2-ERG fusion in an uncommon presentation of prostate cancer

Primary Retroperitoneal Lymph Node Dissection for Stage II Seminoma: Is Surgery the New Path Forward?

Phase I/II trial of plinabulin in combination with nivolumab and ipilimumab in patients with recurrent small cell lung cancer (SCLC): Big ten cancer research consortium (BTCRC-LUN17-127) study

A phase II study assessing the safety and efficacy of ASP1650 in male patients with relapsed refractory germ cell tumors

Surveillance after Complete Response to First-Line Chemotherapy in Patients with Metastatic Nonseminomatous Germ Cell Tumor

Survival outcomes and toxicity in patients 40 years old or older with relapsed metastatic germ cell tumors treated with high‐dose chemotherapy and peripheral blood stem cell transplantation

Nintedanib plus pemetrexed versus placebo plus pemetrexed in patients with relapsed or refractory, advanced non-small cell lung cancer (LUME-Lung 2): A randomized, double-blind, phase III trial

Electronic nicotine delivery systems: a policy statement from the American Association for Cancer Research and the American Society of Clinical Oncology

Suchergebnisse filtern